87 related articles for article (PubMed ID: 17036125)
1. New 64Cu PET imaging agents for personalised medicine and drug development using the hexa-aza cage, SarAr.
Di Bartolo N; Sargeson AM; Smith SV
Org Biomol Chem; 2006 Sep; 4(17):3350-7. PubMed ID: 17036125
[TBL] [Abstract][Full Text] [Related]
2. Sarar technology for the application of Copper-64 in biology and materials science.
Smith SV
Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):193-202. PubMed ID: 18174877
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography (PET) imaging of neuroblastoma and melanoma with 64Cu-SarAr immunoconjugates.
Voss SD; Smith SV; DiBartolo N; McIntosh LJ; Cyr EM; Bonab AA; Dearling JL; Carter EA; Fischman AJ; Treves ST; Gillies SD; Sargeson AM; Huston JS; Packard AB
Proc Natl Acad Sci U S A; 2007 Oct; 104(44):17489-93. PubMed ID: 17954911
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of hexa aza cages, SarAr-NCS and AmBaSar and a study of their metal complexation, conjugation to nanomaterials and proteins for application in radioimaging and therapy.
Mume E; Asad A; Di Bartolo NM; Kong L; Smith C; Sargeson AM; Price R; Smith SV
Dalton Trans; 2013 Oct; 42(40):14402-10. PubMed ID: 23851350
[TBL] [Abstract][Full Text] [Related]
5. In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems.
Garrison JC; Rold TL; Sieckman GL; Figueroa SD; Volkert WA; Jurisson SS; Hoffman TJ
J Nucl Med; 2007 Aug; 48(8):1327-37. PubMed ID: 17631556
[TBL] [Abstract][Full Text] [Related]
6. Investigation into 64Cu-labeled Bis(selenosemicarbazone) and Bis(thiosemicarbazone) complexes as hypoxia imaging agents.
McQuade P; Martin KE; Castle TC; Went MJ; Blower PJ; Welch MJ; Lewis JS
Nucl Med Biol; 2005 Feb; 32(2):147-56. PubMed ID: 15721760
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, Copper(II) Complexation, (64)Cu-Labeling, and Bioconjugation of a New Bis(2-pyridylmethyl) Derivative of 1,4,7-Triazacyclononane.
Gasser G; Tjioe L; Graham B; Belousoff MJ; Juran S; Walther M; Künstler JU; Bergmann R; Stephan H; Spiccia L
Bioconjug Chem; 2008 Mar; 19(3):719-30. PubMed ID: 18254581
[TBL] [Abstract][Full Text] [Related]
8. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
9. Bifunctional (64)Cu-labelled macrobicyclic cage amine isothiocyanates for immuno-positron emission tomography.
Paterson BM; Buncic G; McInnes LE; Roselt P; Cullinane C; Binns DS; Jeffery CM; Price RI; Hicks RJ; Donnelly PS
Dalton Trans; 2015 Mar; 44(11):4901-9. PubMed ID: 25351329
[TBL] [Abstract][Full Text] [Related]
10. A novel method to label preformed liposomes with 64Cu for positron emission tomography (PET) imaging.
Seo JW; Zhang H; Kukis DL; Meares CF; Ferrara KW
Bioconjug Chem; 2008 Dec; 19(12):2577-84. PubMed ID: 18991368
[TBL] [Abstract][Full Text] [Related]
11. Effects of targeting moiety, linker, bifunctional chelator, and molecular charge on biological properties of 64Cu-labeled triphenylphosphonium cations.
Kim YS; Yang CT; Wang J; Wang L; Li ZB; Chen X; Liu S
J Med Chem; 2008 May; 51(10):2971-84. PubMed ID: 18419113
[TBL] [Abstract][Full Text] [Related]
12. In vivo evaluation of 177Lu- and 67/64Cu-labeled recombinant fragments of antibody chCE7 for radioimmunotherapy and PET imaging of L1-CAM-positive tumors.
Grünberg J; Novak-Hofer I; Honer M; Zimmermann K; Knogler K; Bläuenstein P; Ametamey S; Maecke HR; Schubiger PA
Clin Cancer Res; 2005 Jul; 11(14):5112-20. PubMed ID: 16033825
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biologic evaluation of 64Cu-labeled rhenium-cyclized alpha-MSH peptide analog using a cross-bridged cyclam chelator.
Wei L; Butcher C; Miao Y; Gallazzi F; Quinn TP; Welch MJ; Lewis JS
J Nucl Med; 2007 Jan; 48(1):64-72. PubMed ID: 17204700
[TBL] [Abstract][Full Text] [Related]
14. Revisiting dithiadiaza macrocyclic chelators for copper-64 PET imaging.
Shuvaev S; Suturina EA; Rotile NJ; Astashkin A; Ziegler CJ; Ross AW; Walker TL; Caravan P; Taschner IS
Dalton Trans; 2020 Oct; 49(40):14088-14098. PubMed ID: 32970072
[TBL] [Abstract][Full Text] [Related]
15. Conjugation of monoclonal antibodies with TETA using activated esters: biological comparison of 64Cu-TETA-1A3 with 64Cu-BAT-2IT-1A3.
Lewis MR; Boswell CA; Laforest R; Buettner TL; Ye D; Connett JM; Anderson CJ
Cancer Biother Radiopharm; 2001 Dec; 16(6):483-94. PubMed ID: 11789025
[TBL] [Abstract][Full Text] [Related]
16. Tailored Gallium(III) chelator NOPO: synthesis, characterization, bioconjugation, and application in preclinical Ga-68-PET imaging.
Simeček J; Zemek O; Hermann P; Notni J; Wester HJ
Mol Pharm; 2014 Nov; 11(11):3893-903. PubMed ID: 24350645
[TBL] [Abstract][Full Text] [Related]
17. Matching chelators to radiometals for radiopharmaceuticals.
Price EW; Orvig C
Chem Soc Rev; 2014 Jan; 43(1):260-90. PubMed ID: 24173525
[TBL] [Abstract][Full Text] [Related]
18. In vivo evaluation of copper-64-labeled monooxo-tetraazamacrocyclic ligands.
Sun X; Kim J; Martell AE; Welch MJ; Anderson CJ
Nucl Med Biol; 2004 Nov; 31(8):1051-9. PubMed ID: 15607487
[TBL] [Abstract][Full Text] [Related]
19. Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research.
Anderson CJ; Ferdani R
Cancer Biother Radiopharm; 2009 Aug; 24(4):379-93. PubMed ID: 19694573
[TBL] [Abstract][Full Text] [Related]
20. Copper-64 labelling of triazacyclononane-triphosphinate chelators.
Simeček J; Wester HJ; Notni J
Dalton Trans; 2012 Dec; 41(45):13803-6. PubMed ID: 23044866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
